This case study demonstrates how DelveInsight supported an oncology-focused pharmaceutical client in assessing investment opportunities in IL-2 therapies.

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews ...

Use of digital health technology for disease monitoring continues to expand, but data on real-world applications in people ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today ...

Autolus Therapeutics (NASDAQ:AUTL) executives highlighted a “very good first year of launch” for AUCATZYL during the ...

Nanoparticles built from red blood cell membranes and loaded with a sound-sensitive dye kill liver cancer cells when ...

Over the past decades, neuroscience studies have painted an increasingly detailed picture of the human brain, its organization and how it supports various functions. To plan and execute desired ...

New research reveals mechanisms to detect and weaken TB bacteria, offering hope against drug resistance on World TB Day.

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

If your eczema gets worse when you’re stressed, you’re not imagining it. A new study explains what likely happens in the body ...

Q4 2025 Earnings Call March 25, 2026 8:30 AM EDTCompany ParticipantsJisong Cui - Co-Founder, Chairwoman & CEOXin Fu ...